Literature DB >> 30699418

Clearance of Magnesium in Peritoneal Dialysis Patients: A Single-Center Study.

Guiyan Li1, Li Zhang2, Haibin Ren1, Baodi Huang1, Chunxia Mao1, Annan Zhou1.   

Abstract

OBJECTIVE: This retrospective study aimed to investigate the clearance of magnesium (Mg) in peritoneal dialysis (PD) patients and its influencing factors.
METHODS: The demographic information, clinical characteristics and laboratory data of the patients were collected. According to the corrected serum Mg (cS-Mg) concentration, patients were divided into 3 groups including hypomagnesemia (Mg2+ < 0.77 mmol/L, group A), normal serum Mg concentration (0.77 mmol/L ≤ Mg2+ ≤1.03 mmol/L, group B), and hypermagnesemia (Mg2+ > 1.03 mmo/L, group C).
RESULTS: One hundred and fifteen patients were enrolled, and their mean 24 h-peritoneal Mg clearance was 39.75 ± 17.42 mg. The mean normalized peritoneal Mg clearance rate was 1.82 ± 0.82 L/day/1.73 m2. Twenty-four-hour peritoneal Mg clearance of group A was significantly lower than that of group C (p < 0.05). Bivariate correlation analysis showed that cS-Mg was positively correlated with peritoneal dialysate Mg concentration (p < 0.01). cS-Mg was negatively correlated with the normalized peritoneal Mg clearance rate (p < 0.05). The normalized peritoneal Mg clearance rate was positively correlated with prealbumin (p < 0.05), daily peritoneal protein loss (p < 0.01) and the normalized PD-creatinine clearance rate (p < 0.01). The normalized peritoneal Mg clearance rate was also negatively correlated with the normalized renal-creatinine clearance rate (p < 0.01). Furthermore, cS-Mg of patients with continuous ambulatory PD (CAPD) was significantly lower than that of patients with daytime ambulatory PD (DAPD, p < 0.01). The normalized peritoneal Mg clearance rate of patients with CAPD was significantly higher than that of patients with DAPD (p < 0.01). Moreover, among the patients with different peritoneal transport characteristics of peritoneal equilibration test, the normalized peritoneal Mg clearance rate of high average transport patients was significantly higher than that in those with low transport, low average transport and high transport (p < 0.05).
CONCLUSIONS: Serum Mg could be partly cleared by PD. The peritoneal Mg clearance was positively related with serum Mg concentration, which was concentration-dependent. Peritoneal Mg clearance was negatively correlated with the residual renal function, while being positively correlated with the nutritional status and daily peritoneal protein loss. Peritoneal Mg clearance was higher in patients with high transport characteristics or CAPD.
© 2019 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Clearance; Peritoneal dialysate magnesium concentrations; Peritoneal dialysis; Serum magnesium

Mesh:

Substances:

Year:  2019        PMID: 30699418      PMCID: PMC6518854          DOI: 10.1159/000496217

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  7 in total

1.  HYPERMAGNESEMIA IN RENAL FAILURE. ETIOLOGY AND TOXIC MANIFESTATIONS.

Authors:  R E RANDALL; M D COHEN; C C SPRAY; E C ROSSMEISL
Journal:  Ann Intern Med       Date:  1964-07       Impact factor: 25.391

2.  Minerals, vitamin D, and parathyroid hormone in continuous ambulatory peritoneal dialysis.

Authors:  J A Delmez; E Slatopolsky; K J Martin; B N Gearing; H R Harter
Journal:  Kidney Int       Date:  1982-06       Impact factor: 10.612

Review 3.  Magnesium and Dialysis: The Neglected Cation.

Authors:  Mohamad Alhosaini; David J Leehey
Journal:  Am J Kidney Dis       Date:  2015-04-09       Impact factor: 8.860

4.  Magnesium homeostasis in patients undergoing continuous ambulatory peritoneal dialysis: role of the dialysate magnesium concentration.

Authors:  Kostas P Katopodis; Elli L Koliousi; Emilios K Andrikos; Michael V Pappas; Moses S Elisaf; Kostas C Siamopoulos
Journal:  Artif Organs       Date:  2003-09       Impact factor: 3.094

5.  Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients.

Authors:  John Cunningham; Mariano Rodríguez; Piergiorgio Messa
Journal:  Clin Kidney J       Date:  2012-02

6.  Serum Magnesium and Sudden Death in European Hemodialysis Patients.

Authors:  Camiel L M de Roij van Zuijdewijn; Muriel P C Grooteman; Michiel L Bots; Peter J Blankestijn; Sonja Steppan; Janine Büchel; Rolf H H Groenwold; Vincent Brandenburg; Marinus A van den Dorpel; Piet M Ter Wee; Menso J Nubé; Marc G Vervloet
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

7.  Hypomagnesemia Is Associated with Increased Mortality among Peritoneal Dialysis Patients.

Authors:  Kedan Cai; Qun Luo; Zhiwei Dai; Beixia Zhu; Jinping Fei; Congping Xue; Dan Wu
Journal:  PLoS One       Date:  2016-03-29       Impact factor: 3.240

  7 in total
  1 in total

Review 1.  Extracorporeal blood purification treatment options for COVID-19: The role of immunoadsorption.

Authors:  Tuğçe Nur Yiğenoğlu; Turgay Ulas; Mehmet Sinan Dal; Serdal Korkmaz; Mehmet Ali Erkurt; Fevzi Altuntaş
Journal:  Transfus Apher Sci       Date:  2020-06-25       Impact factor: 2.596

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.